MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from long-term
debt, net of issuance...
$24,467K
Issuance of class a
ordinary shares, net of...
$6,007K
Proceeds from options
exercised-Equity Incentive Plan
$170K
Proceeds from maturities
of short-term...
$59,166K
Net cash flow
provided by financing...
$30,644K
Net cash flow
provided by investing...
$98K
Canceled cashflow
$59,068K
Net change in cash
and cash...
-$36,027K
Canceled cashflow
$30,742K
Share-based compensation
expense
$13,355K
Accrued expenses and
other current...
$7,123K
Depreciation and
amortization
$845K
Other non-cash items
-$422K
Net periodic
pension benefit gain...
$11K
Purchase of short-term
marketable debt securities
$59,068K
Net cash flow used in
operating activities
-$66,286K
Canceled cashflow
$21,756K
Effect of movements in
exchange rates on cash...
-$483K
Net loss
-$69,707K
Prepaid expenses
$10,100K
Trade and other
payables
-$6,173K
Other receivables
$894K
Other non-current
assets
$749K
Operating lease
liabilities
-$389K
Operating lease
right-of-use assets
$30K
Back
Back
Cash Flow
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX)
source: myfinsight.com